National Influenza Mid-Season Report, 2019-2020

Claire Sevenhuysen1, Liza Lee1, Andrea Nwosu1

  • 1Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.

Insights

Canada

Area of Science:

  • Public Health
  • Virology
  • Epidemiology

Background:

  • Canada's national influenza season began in late November 2019.
  • Influenza A(H3N2) and Influenza B were the predominant strains detected early in the season.
  • Influenza B detections were higher than average for the period.

Purpose of the Study:

  • To report on the early-season activity of influenza in Canada.
  • To describe the characteristics of laboratory-confirmed influenza cases and hospitalizations.
  • To assess the similarity of circulating influenza strains to the 2019-2020 seasonal vaccine components.

Main Methods:

  • Laboratory confirmation of influenza detections.
  • Subtyping of influenza A viruses.
  • Analysis of hospitalization data from sentinel sites and provincial/territorial reports.
  • Antigenic and genetic characterization of circulating influenza viruses.

Main Results:

  • Influenza A accounted for 61% of detections, with A(H3N2) being the most common subtype.
  • Influenza A(H3N2) was associated with 76% of reported hospitalizations, primarily in adults aged 65 and older.
  • Influenza B was associated with 55% of pediatric hospitalizations, predominantly in children under five.
  • Circulating A(H3N2) and B strains showed limited similarity to the 2019-2020 vaccine viruses, while A(H1N1) strains were similar.

Conclusions:

  • Early influenza season activity in Canada was characterized by a predominance of Influenza A(H3N2) and higher-than-average Influenza B detections.
  • Significant proportions of hospitalizations were linked to Influenza A(H3N2) in older adults and Influenza B in young children.
  • A mismatch was observed between circulating A(H3N2) and B strains and the recommended vaccine components for the 2019-2020 season.